Literature DB >> 6480071

The immunological basis of inflammatory diseases.

J F Bach.   

Abstract

Most immunologically-mediated diseases are inflammatory in nature, as assessed by cellular infiltrates at the lesion site. Recent immunohistological studies using monoclonal antibodies on tissue sections and synovial or cerebrospinal fluid reveal that B- and T-lymphocytes (predominantly T) participate in this reaction, together with monocytes and macrophages. The etiopathogenesis of inflammatory diseases of immunological origin can be discussed at two levels. (1) Lesions may be secondary to the cytopathic effect of antibodies, either by direct cytolysis or by opsonization, antigenic modulation, or blockage of functionally-relevant molecules. Immune complexes formed in the circulation or locally at the lesion site may intervene. Direct cellular mechanisms are probably involved, as suggested by evidence in hepatitis (indirect) and in juvenile insulin-dependent diabetes (direct). K-cells may act by antibody-dependent cytotoxicity, particularly in autoimmune diabetes and thyroiditis where lymphocyte-dependent antibodies are demonstrated. Unfortunately, the absence of adequate markers does not permit adequate detection of K-cells in inflammatory reaction sites. (2) Etiological factors are multiple in a given disease and even in a single patient. Deficiency of suppressor T-cells, assessed using monoclonal anti T-cell antibodies, represents a major predisposing factor, although suppressor cell deficit may be restricted to some antigens (EBV) in certain patients. The deficiency of interleukin-2 production in lupus and rheumatoid arthritis is intriguing but the mechanism and its relationship to disease etiology are unknown. Other immunological factors include intrinsic B-cell hyperactivity, anti-T-cell auto-antibodies, and complement deficiencies, whereas non-immunological factors such as viruses, drugs or sex hormones are important but ill-defined.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480071     DOI: 10.1007/bf00915711

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  6 in total

1.  Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.

Authors:  V A Lennon; E H Lambert
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

Review 2.  In situ formation of glomerular immune aggregates.

Authors:  P J Hoedmaeker; G J Fleuren; J J Weening
Journal:  Transplant Proc       Date:  1982-09       Impact factor: 1.066

Review 3.  Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis.

Authors:  J M Depper; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1981-06

Review 4.  The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases.

Authors:  M A Bach; J F Bach
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

5.  In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon.

Authors:  C Boitard; L M Chatenoud; M Debray-Sachs
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

6.  T, B and K cells in autoimmune thyroid disease.

Authors:  E A Calder; W J Irvine; N M Davidson; F Wu
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.